ROCK2
Rho-associated protein kinase 2
Also known as: ROCK2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75116
- Gene
- ROCK2
- Ensembl
- ENSG00000134318
- Chromosome
- 2
- Canonical length
- 1388 aa
- Protein class
- Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1 is a target for the small GTPase Rho. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1388 residues, UniProt reviewed canonical sequence.
>O75116|ROCK2
1 MSRPPPTGKM PGAPETAPGD GAGASRQRKL EALIRDPRSP INVESLLDGL NSLVLDLDFP
61 ALRKNKNIDN FLNRYEKIVK KIRGLQMKAE DYDVVKVIGR GAFGEVQLVR HKASQKVYAM
121 KLLSKFEMIK RSDSAFFWEE RDIMAFANSP WVVQLFYAFQ DDRYLYMVME YMPGGDLVNL
181 MSNYDVPEKW AKFYTAEVVL ALDAIHSMGL IHRDVKPDNM LLDKHGHLKL ADFGTCMKMD
241 ETGMVHCDTA VGTPDYISPE VLKSQGGDGF YGRECDWWSV GVFLYEMLVG DTPFYADSLV
301 GTYSKIMDHK NSLCFPEDAE ISKHAKNLIC AFLTDREVRL GRNGVEEIRQ HPFFKNDQWH
361 WDNIRETAAP VVPELSSDID SSNFDDIEDD KGDVETFPIP KAFVGNQLPF IGFTYYRENL
421 LLSDSPSCRE TDSIQSRKNE ESQEIQKKLY TLEEHLSNEM QAKEELEQKC KSVNTRLEKT
481 AKELEEEITL RKSVESALRQ LEREKALLQH KNAEYQRKAD HEADKKRNLE NDVNSLKDQL
541 EDLKKRNQNS QISTEKVNQL QRQLDETNAL LRTESDTAAR LRKTQAESSK QIQQLESNNR
601 DLQDKNCLLE TAKLKLEKEF INLQSALESE RRDRTHGSEI INDLQGRICG LEEDLKNGKI
661 LLAKVELEKR QLQERFTDLE KEKSNMEIDM TYQLKVIQQS LEQEEAEHKA TKARLADKNK
721 IYESIEEAKS EAMKEMEKKL LEERTLKQKV ENLLLEAEKR CSLLDCDLKQ SQQKINELLK
781 QKDVLNEDVR NLTLKIEQET QKRCLTQNDL KMQTQQVNTL KMSEKQLKQE NNHLMEMKMN
841 LEKQNAELRK ERQDADGQMK ELQDQLEAEQ YFSTLYKTQV RELKEECEEK TKLGKELQQK
901 KQELQDERDS LAAQLEITLT KADSEQLARS IAEEQYSDLE KEKIMKELEI KEMMARHKQE
961 LTEKDATIAS LEETNRTLTS DVANLANEKE ELNNKLKDVQ EQLSRLKDEE ISAAAIKAQF
1021 EKQLLTERTL KTQAVNKLAE IMNRKEPVKR GNDTDVRRKE KENRKLHMEL KSEREKLTQQ
1081 MIKYQKELNE MQAQIAEESQ IRIELQMTLD SKDSDIEQLR SQLQALHIGL DSSSIGSGPG
1141 DAEADDGFPE SRLEGWLSLP VRNNTKKFGW VKKYVIVSSK KILFYDSEQD KEQSNPYMVL
1201 DIDKLFHVRP VTQTDVYRAD AKEIPRIFQI LYANEGESKK EQEFPVEPVG EKSNYICHKG
1261 HEFIPTLYHF PTNCEACMKP LWHMFKPPPA LECRRCHIKC HKDHMDKKEE IIAPCKVYYD
1321 ISTAKNLLLL ANSTEEQQKW VSRLVKKIPK KPPAPDPFAR SSPRTSMKIQ QNQSIRRPSR
1381 QLAPNKPSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ROCK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 34 nTPM
- blood vessel: 30 nTPM
- skeletal muscle: 29 nTPM
- tongue: 28 nTPM
- smooth muscle: 26 nTPM
- rectum: 24 nTPM
Single-cell type
- myonuclei: 529 nCPM
- adipocytes: 452 nCPM
- vascular smooth muscle cells: 430 nCPM
- smooth muscle cells: 405 nCPM
- salivary myoepithelial cells: 398 nCPM
- pericytes: 387 nCPM
Immune cell
- MAIT T-cell: 0.4 nTPM
- plasmacytoid DC: 0.4 nTPM
- intermediate monocyte: 0.3 nTPM
- NK-cell: 0.3 nTPM
- classical monocyte: 0.2 nTPM
- eosinophil: 0.2 nTPM
Brain region
- cerebellum: 58 nTPM
- basal ganglia: 54 nTPM
- cerebral cortex: 50 nTPM
- hippocampal formation: 46 nTPM
- white matter: 42 nTPM
- thalamus: 36 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.38
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- actomyosin structure organization
- aortic valve morphogenesis
- blood vessel diameter maintenance
- cellular response to acetylcholine
- centrosome duplication
- cortical actin cytoskeleton organization
- embryonic morphogenesis
- epithelial to mesenchymal transition
- host-mediated perturbation of viral process
- mitotic cytokinesis
- mRNA destabilization
- negative regulation of angiogenesis
- negative regulation of bicellular tight junction assembly
- negative regulation of biomineral tissue development
- negative regulation of gene expression
- negative regulation of nitric oxide biosynthetic process
- negative regulation of protein localization to lysosome
- positive regulation of amyloid precursor protein catabolic process
- positive regulation of amyloid-beta formation
- positive regulation of cardiac muscle hypertrophy
- positive regulation of cell migration
- positive regulation of centrosome duplication
- positive regulation of connective tissue replacement
- positive regulation of fibroblast growth factor production
- positive regulation of gene expression
- positive regulation of MAPK cascade
- positive regulation of protein localization to early endosome
- positive regulation of stress fiber assembly
- protein localization to plasma membrane
- protein phosphorylation
- regulation of actin cytoskeleton organization
- regulation of angiotensin-activated signaling pathway
- regulation of cell adhesion
- regulation of cell junction assembly
- regulation of cell motility
- regulation of cellular response to hypoxia
- regulation of circadian rhythm
- regulation of establishment of cell polarity
- regulation of establishment of endothelial barrier
- regulation of focal adhesion assembly
- regulation of keratinocyte differentiation
- regulation of nervous system process
- regulation of stress fiber assembly
- response to angiotensin
- response to ischemia
- response to transforming growth factor beta
- Rho protein signal transduction
- rhythmic process
- smooth muscle contraction
- positive regulation of connective tissue growth factor production
Molecular functions
- ATP binding
- endopeptidase activator activity
- protease binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- Rho-dependent protein serine/threonine kinase activity
- RNA binding
- small GTPase binding
- structural molecule activity
- tau protein binding
- tau-protein kinase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- AGC-kinase, C-terminal
- Pleckstrin homology domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- HR1 rho-binding domain
- PH-like domain superfamily
- ROCK, Rho binding domain
- Protein kinase, ATP binding site
- Rho-associated protein kinase 1/2
- C1-like domain superfamily
- Rho-associated Serine/Threonine Kinase
- MRCK/ROCK kinase, PH domain
- Protein kinase domain
- Rho Binding
- MRCK kinase PH domain
- Rho-associated protein kinase 2, catalytic domain
- Rho-associated protein kinase 2, HR1 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ROCK2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ROCK2 as an antibody target. Whether an autoantibody or antibody against ROCK2 could matter depends on whether native ROCK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ROCK2 is annotated at the cell surface, where native ROCK2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ROCK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...